Document is current
Any future updates will be listed below
-
Authors
Queen, Jessica
Cing, Zam
Minsky, Hana
Nandi, Asmita
Southward, Taylor
Ferri, Jacqueline
McMann, Madison
Iyadorai, Thevambiga
Vadivelu, Jamuna
Roslani, April
Loke, Mun Fai
Wanyiri, Jane
White, James R.
Drewes, Julia L.
Sears, Cynthia L.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32-A1007291)
Biocodex Microbiota Foundation
Burroughs Wellcome Fund (1022128)
Emerald Foundation (Black in Cancer Award)
National Institute of General Medical Sciences (T34-GM136497, 3-T32-GM136577)
Universiti Malaya (RP016A-13HTM)
National Cancer Institute (R00 CA230192)
Bloomberg Philanthropies
Cancer Research UK (Cancer Grand Challenges OPTIMISTICC team grant A27140)
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 1 May 2025
First Online: 20 May 2025
Competing interests
: C.L.S. has received research funding to Johns Hopkins University from Bristol-Myers Squibb and Janssen, and royalties from Up to Date outside the submitted work. J.R.W. reports equity ownership of Resphera Biosciences.
